| RS2496208753 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496210221 |
KMT5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2496211929 |
HEPHL1
|
Health Risk |
Likely pathogenic |
Pili torti-developmental delay-neurological abnormalities syndrome, Pili torti-developmental delay-neurological abnormalities syndrome |
| RS2496221057 |
CEP57
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 2, Mosaic variegated aneuploidy syndrome 2 |
| RS2496224973 |
TRPC6
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 2, Focal segmental glomerulosclerosis 2 |
| RS2496225413 |
TRPC6
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 2, Focal segmental glomerulosclerosis 2 |
| RS2496225710 |
TRPC6
|
Health Risk |
Likely pathogenic |
— |
| RS2496225722 |
TRPC6
|
Health Risk |
Likely pathogenic |
— |
| RS2496232377 |
C2CD3
|
Health Risk |
Pathogenic |
— |
| RS2496234517 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496236257 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496243325 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS2496251511 |
B3GAT3
|
Health Risk |
Pathogenic |
Larsen-like syndrome, B3GAT3 type |
| RS2496251561 |
B3GAT3
|
Health Risk |
Pathogenic |
Larsen-like syndrome, B3GAT3 type |
| RS2496256205 |
PLCE1
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 3 |
| RS2496256443 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2496256527 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496257055 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS2496258057 |
B3GAT3
|
Health Risk |
Pathogenic |
Larsen-like syndrome, B3GAT3 type |
| RS2496263182 |
CEP57
|
Health Risk |
Likely pathogenic |
Mosaic variegated aneuploidy syndrome 2, Mosaic variegated aneuploidy syndrome 2 |
| RS2496264014 |
SPTBN2
|
Health Risk |
Likely pathogenic |
— |
| RS2496272489 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS2496277115 |
SPTBN2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 14, Autosomal recessive spinocerebellar ataxia 14 |
| RS2496279393 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496279887 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496280307 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496280818 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2496281483 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496281774 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496286836 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496288024 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496288376 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS2496288415 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496289320 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496289556 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS2496291260 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496291378 |
GANAB
|
Health Risk |
Pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496292641 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496292658 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS2496293545 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2496294228 |
GANAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496294637 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2496295153 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496295808 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496296355 |
FAM111A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Osteocraniostenosis |
| RS2496297231 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2496297509 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496297949 |
MRE11
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496299328 |
PAX6
|
Health Risk |
Likely pathogenic |
Coloboma, ocular |
| RS2496300697 |
GANAB
|
Health Risk |
Pathogenic |
— |
| RS2496302668 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2496303235 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS2496303443 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496303476 |
CFAP300
|
Health Risk |
Likely pathogenic |
Ciliary dyskinesia, primary |
| RS2496306498 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496306947 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496307620 |
PAX6
|
Health Risk |
Pathogenic |
Congenital aniridia, Congenital aniridia |
| RS2496309388 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS2496312636 |
ALKBH8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 71 |
| RS2496316533 |
GANAB
|
Health Risk |
Likely pathogenic |
— |
| RS2496317302 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496318039 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496320129 |
GANAB
|
Health Risk |
Pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496321996 |
KMT5B
|
Health Risk |
Likely pathogenic |
KMT5B-related disorder, KMT5B-related disorder |
| RS2496323700 |
CHAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496323932 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496332587 |
GANAB
|
Health Risk |
Likely pathogenic |
GANAB-related disorder, GANAB-related disorder |
| RS2496332664 |
GANAB
|
Health Risk |
Pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496333718 |
GANAB
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496335021 |
CFAP300
|
Health Risk |
Pathogenic |
— |
| RS2496336087 |
CEP57
|
Health Risk |
Conflicting classifications of pathogenicity |
Mosaic variegated aneuploidy syndrome 2, Inborn genetic diseases |
| RS2496336176 |
GANAB
|
Health Risk |
Pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS2496345285 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS2496345542 |
PDE2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2496350900 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS2496352247 |
CFAP300
|
Health Risk |
Pathogenic |
— |
| RS2496352818 |
NARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 24, Combined oxidative phosphorylation defect type 24 |
| RS2496353192 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496353578 |
CHAT
|
Health Risk |
Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496357868 |
GANAB
|
Health Risk |
Pathogenic |
— |
| RS2496360223 |
MYO7A
|
Health Risk |
Pathogenic |
— |
| RS2496360541 |
MRE11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2496360780 |
MRE11
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia-like disorder 1, Ataxia-telangiectasia-like disorder 1 |
| RS2496361252 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2496361666 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2496362649 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496363164 |
CHAT
|
Health Risk |
Pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS2496365964 |
NARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 24, Combined oxidative phosphorylation defect type 24 |
| RS2496366381 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2496371393 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2496375170 |
GANAB
|
Health Risk |
Pathogenic |
— |
| RS2496377313 |
DYNC2H1
|
Health Risk |
Pathogenic |
DYNC2H1-related disorder, DYNC2H1-related disorder |
| RS2496380462 |
KMT5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2496380553 |
KMT5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 51 |
| RS2496383930 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2496384376 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2496384636 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS2496384744 |
MRE11
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder |
| RS2496385032 |
LRP5
|
Health Risk |
Likely pathogenic |
Exudative vitreoretinopathy 4, Exudative vitreoretinopathy 4 |
| RS2496385150 |
LRP5
|
Health Risk |
Pathogenic |
— |